Postpartum haemorrhage, Prognosis, Blood loss, IPD meta-analysis, Prognostic accuracy, Clinical markers
Maternal mortality, Maternal health, Postpartum haemorrhage, Postpartum hemorrhage, SDG 3.1, IPD meta-analysis
diagnostic tests, health technology assessment, value proposition, test effects, test accuracy, clinical pathway